vai alle Pubblicazioni
Publications prior to 2004
67
: Bavelloni A, Poli A, Fiume R, Blalock W, Matteucci
A, Ramazzotti G, McCubrey JA, Cocco L, Faenza I. PLC-beta 1
regulates the expression of miR-210 during mithramycin-mediated
erythroid differentiation in K562 cells.
Oncotarget 2014. Accepted and in press . (IF: 6,63)
66
: Bavelloni A, Piazzi M, Faenza I, Raffini M, D'Angelo A,
Cattini L, Cocco L, Blalock WL.
Prohibitin 2 represents a novel nuclear AKT substrate during
all-trans retinoic acid-induced differentiation of acute
promyelocytic leukemia cells. FASEB J. 2014 Feb 12. PubMed
PMID: 24522204. (IF: 5,704)
65
: Blalock WL, Piazzi M, Bavelloni A, Raffini M, Faenza I,
D'Angelo A, Cocco L. Identification of the PKR Nuclear Interactome
Reveals Roles in Ribosome Biogenesis, mRNA Processing and Cell
Division. J Cell Physiol. 2013 Dec 18. doi: 10.1002/jcp.24529.
PubMed PMID: 24347309. (IF:4,218)
64
: Follo MY, Faenza I, Piazzi M, Blalock WL, Manzoli L,
McCubrey JA, Cocco L. Nuclear PI-PLC
β
1: an appraisal on targets and pathology. Adv Biol Regul. 2014
Jan;54:2-11. doi: 10.1016/j.jbior.2013.11.003. Epub 2013 Nov 20.
PubMed PMID: 24296032.
63
: Faenza I, Fiume R, Piazzi M, Colantoni A, Cocco L. Nuclear
inositide specific phospholipase C
signalling - interactions and activity. FEBS J. 2013
Dec;280(24):6311-21. doi: 10.1111/febs.12450.
Epub 2013 Aug 20. Review. PubMed PMID: 23890371.
(IF:4,25)
62
: Piazzi M, Blalock WL, Bavelloni A, Faenza I, D'Angelo A,
Maraldi NM, Cocco L.
Phosphoinositide-specific phospholipase C
β
1b (PI-PLC
β
1b) interactome: affinity purification-mass spectrometry analysis
of PI PLC
β
1b with nuclear protein. Mol Cell Proteomics. 2013
Aug;12(8):2220-35. doi:10.1074/mcp.M113.029686. Epub 2013 May
9. PubMed PMID: 23665500; PubMed Central PMCID: PMC3734581. (IF:
7,398)
61
: Poli A, Faenza I, Chiarini F, Matteucci A, McCubrey JA,
Cocco L. K562 cell proliferation is modulated by PLC
β
1 through a PKC
α
-mediated pathway. Cell Cycle. 2013 Jun 1;12(11):1713-21. doi:
10.4161/cc.24806. Epub 2013 May 6. PubMed PMID: 23656785; PubMed
Central PMCID: PMC3713130. (IF: 5.24)
60
: Follo MY, Marmiroli S, Faenza I, Fiume R, Ramazzotti G,
Martelli AM, Gobbi P, McCubrey JA, Finelli C, Manzoli FA, Cocco L.
Nuclear phospholipase C
β
1 signaling, epigenetics and treatments in MDS. Adv Biol Regul.
2013 Jan;53(1):2-7.doi: 10.1016/j.jbior.2012.09.009. Epub 2012 Sep
21. Review. PubMed PMID:23058275.
59
: Faenza I, Blalock W, Bavelloni A, Schoser B, Fiume R,
Pacella S, Piazzi M, D'Angelo A, Cocco L. A role for
PLC
β
1 in myotonic dystrophies type 1 and 2. FASEB J. 2012
Jul;26(7):3042-8. doi: 10.1096/fj.11-200337. Epub 2012 Mar 29.
PubMedPMID: 22459146.(IF: 5,704)
58
: Fiume R, Keune WJ, Faenza I, Bultsma Y, Ramazzotti G,
Jones DR, Martelli AM, Somner L, Follo MY, Divecha N, Cocco L.
Nuclear phosphoinositides: location,regulation and function.
Subcell Biochem. 2012;59:335-61. doi: 10.1007/978-94-007-3015-1_11.
PubMed PMID: 22374096.
57
: Follo MY, Mongiorgi S, Finelli C, Piazzi M, Faenza I,
Ramazzotti G, Santi P, McCubrey JA, Martelli AM, Cocco L.
Nuclear PI-PLC
β
1 and myelodysplastic syndromes: genetics and epigenetics. Curr
Pharm Des. 2012;18(13):1751-4. Review. PubMed PMID: 22352752. (IF:
3,311)
56
: Ramazzotti G, Faenza I, Follo MY, Fiume R, Piazzi M,
Giardino R, Fini M, Cocco L. Nuclear phospholipase C in biological
control and cancer.
Crit RevEukaryot Gene Expr. 2011;21(3):291-301. Review. PubMed
PMID: 22111715. (IF: 2,07)
55
: Follo MY, Faenza I, Fiume R, Ramazzotti G, McCubrey JA,
Martelli AM, Manzoli FA, Cocco L. Revisiting nuclear
phospholipase C signalling in MDS. Adv Biol Regul. 2012
Jan;52(1):2-6. Review. PubMed PMID: 21982979.
54
: Fiume R, Ramazzotti G, Faenza I, Piazzi M, Bavelloni A,
Billi AM, Cocco L. Nuclear PLCs affect insulin secretion by
targeting PPAR
γ
in pancreatic
β
cells. FASEB J. 2012 Jan;26(1):203-10. doi: 10.1096/fj.11-186510.
Epub 2011 Oct 5.PubMed PMID: 21974932. (IF: 5,704)
53
: Blalock WL, Bavelloni A, Piazzi M, Tagliavini F, Faenza I,
Martelli AM, Follo MY, Cocco L. Multiple forms of PKR present in
the nuclei of acute leukemia cells represent an active kinase that
is responsive to stress. Leukemia. 2011 Feb;25(2):236-45. doi:
10.1038/leu.2010.264. Epub 2010 Nov 12. PubMed PMID: 21072047.(IF:
10,64)
52
: Cocco L, Follo MY, Faenza I, Fiume R, Ramazzotti G, Weber
G, Martelli AM, Manzoli FA.
Physiology and pathology of nuclear phospholipase C
β
1. Adv Enzyme Regul. 2011;51(1):2-12. doi:
10.1016/j.advenzreg.2010.09.015. Epub 2010 Oct 28. Review. PubMed
PMID: 21035488.
51
: Piazzi M, Bavelloni A, Faenza I, Blalock W, Urbani A,
D'Aguanno S, Fiume R, Ramazzotti G, Maraldi NM, Cocco L. eEF1A
phosphorylation in the nucleus of insulin-stimulated C2C12
myoblasts: Ser
⁵³
is a novel substrate for protein kinase C
β
I. Mol Cell Proteomics. 2010 Dec;9(12):2719-28. doi:
10.1074/mcp.M110.003152. Epub 2010 Oct 5. PubMed PMID:
20923971; PubMed Central PMCID: PMC3101858. (IF: 7,398)
50
: Ramazzotti G*, Faenza I*, Fiume R, Matteucci A, Piazzi M, Follo MY,
Cocco L. The physiology and pathology of inositide signaling in the
nucleus. J Cell Physiol. 2011 Jan;226(1):14-20. doi:
10.1002/jcp.22334. Review. PubMed PMID:20658523. (IF:4,218)
*contributed equally to this
work
49
: Fiume R, Teti G, Faenza I, Cocco L.
Phosphoinositide-specific phospholipase C beta1 signal transduction
in the nucleus. Methods Mol Biol. 2010;645:143-64.
doi:10.1007/978-1-60327-175-2_10. PubMed PMID: 20645187.
48
: Blalock WL, Bavelloni A, Piazzi M, Faenza I, Cocco L. A
role for PKR in hematologic malignancies. J Cell Physiol. 2010
Jun;223(3):572-91. doi: 10.1002/jcp.22092. PubMed PMID: 20232306.
(IF:4,218)
47
: Follo MY, Mongiorgi S, Finelli C, Clissa C, Ramazzotti G, Fiume
R, Faenza I, Manzoli L, Martelli AM, Cocco L. Nuclear
inositide signaling in myelodysplastic syndromes.
J Cell Biochem. 2010 Apr 15;109(6):1065-71. doi: 10.1002/jcb.22483.
Review. PubMed PMID: 20058233.(IF: 3,062)
46
: Bertagnolo V, Grassilli S, D'Aguanno S, Brugnoli F, Bavelloni A,
Faenza I,Nika E, Urbani A, Cocco L, Capitani S. Mass
spectrometry-based identification of Y745 of Vav1 as a
tyrosine residue crucial in maturation of acute promyelocytic
leukemia-derived cells. J Proteome Res. 2010 Feb 5;9(2):752-60.
doi:10.1021/pr900581y. PubMed PMID: 20028078. (IF:
5,506)
45
: Gaboardi GC, Ramazzotti G, Bavelloni A, Piazzi M, Fiume R, Billi
AM,Matteucci A, Faenza I, Cocco L. A role for PKCepsilon
during C2C12 myogenic differentiation.
Cell Signal. 2010 Apr;22(4):629-35.
doi:10.1016/j.cellsig.2009.11.017. Epub 2009 Nov 29. PubMed PMID:
19954762.(IF: 4,060)
44
: Cocco L, Follo MY, Faenza I, Billi AM, Ramazzotti G,
Martelli AM, Manzoli L, Weber G. Inositide signaling in the
nucleus: from physiology to pathology. Adv Enzyme Regul.
2010;50(1):2-11. doi: 10.1016/j.advenzreg.2009.10.007. Epub 2009Nov
4. Review. PubMed PMID: 19895834.
43
: O'Carroll SJ, Mitchell MD, Faenza I, Cocco L, Gilmour RS.
Nuclear PLCbeta1 is required for 3T3-L1 adipocyte differentiation
and regulates expression of the cyclin D3-cdk4 complex. Cell
Signal. 2009 Jun;21(6):926-35. PubMed PMID:19385066. (IF:
4,060)
42
: Cocco L, Faenza I, Follo MY, Billi AM, Ramazzotti G, Papa
V, Martelli AM, Manzoli L. Nuclear inositides: PI-PLC signaling in
cell growth, differentiation and pathology. Adv Enzyme Regul.
2009;49(1):2-10. doi: 10.1016/j.advenzreg.2008.12.001. Epub 2008
Dec 31. Review. PubMed PMID: 19159640.
41
: Fiume R, Ramazzotti G, Teti G, Chiarini F, Faenza I,
Mazzotti G, Billi AM, Cocco L. Involvement of nuclear PLCbeta1 in
lamin B1 phosphorylation and G2/M cell cycle progression. FASEB J.
2009 Mar;23(3):957-66. doi:10.1096/fj.08-121244. Epub 2008 Nov 21.
PubMed PMID: 19028838. . (IF: 5,704)
40
: Ramazzotti G, Faenza I, Gaboardi GC, Piazzi M, Bavelloni
A, Fiume R, Manzoli L, Martelli AM, Cocco L. Catalytic
activity of nuclear PLC-beta(1) is required for its signalling
function during C2C12 differentiation. Cell Signal. 2008
Nov;20(11):2013-21. doi: 10.1016/j.cellsig.2008.07.009. Epub 2008
Jul 20. PubMed PMID: 18694821. (due primi nomi) (IF:
4,060)
39
: Cocco L, Faenza I, Follo MY, Ramazzotti G, Gaboardi GC,
Billi AM, Martelli AM, Manzoli L. Inositide signaling: Nuclear
targets and involvement in myelodysplastic syndromes. Adv Enzyme
Regul. 2008;48:2-9. doi:10.1016/j.advenzreg.2007.11.013. Epub 2008
Mar 17. Review. PubMed PMID: 18280812.
38: Faenza I
, Bregoli L, Ramazzotti G, Gaboardi G, Follo MY, Mongiorgi S, Billi
AM, Manzoli L, Martelli AM, Cocco L. Nuclear phospholipase C beta1
and cellular differentiation. Front Biosci. 2008 Jan 1;13:2452-63.
Review. PubMed PMID:17981726.(IF:3,063)
37
: Cocco L, Follo MY, Faenza I, Bavelloni A, Billi AM,
Martelli AM, Manzoli L. Nuclear inositide signaling: an appraisal
of phospholipase C beta 1 behavior in myelodysplastic and leukemia
cells. Adv Enzyme Regul. 2007;47:2-9. Epub 2007 Mar 1. Review.
PubMed PMID: 17335878.
36
: Faenza I, Ramazzotti G, Bavelloni A, Fiume R, Gaboardi GC,
Follo MY, Gilmour RS, Martelli AM, Ravid K, Cocco L.
Inositide-dependent phospholipase C signaling mimics insulin
in skeletal muscle differentiation by affecting specific regions of
the cyclin D3 promoter. Endocrinology. 2007 Mar;148(3):1108-17.
Epub 2006 Nov 22. PubMed PMID: 17122077. (IF: 4,833)
35
: Bavelloni A, Faenza I, Cioffi G, Piazzi M, Parisi D, Matic
I, Maraldi NM, Cocco L. Proteomic-based analysis of nuclear
signaling: PLCbeta1 affects the expression of the splicing factor
SRp20 in Friend erythroleukemia cells.
Proteomics. 2006 Nov;6(21):5725-34. PubMed PMID: 17022104. (IF:
4,132)
34
: Evangelisti C, Riccio M, Faenza I, Zini N, Hozumi Y, Goto
K, Cocco L,Martelli AM.
Subnuclear localization and differentiation-dependent increased
expression of DGK-zeta in C2C12 mouse myoblasts. J Cell Physiol.
2006 Nov;209(2):370-8. PubMed PMID: 16897754. (IF:4,218)
33
: Cocco L, Martelli AM, Fiume R, Faenza I, Billi AM, Manzoli
FA.
Signal transduction within the nucleus: revisiting phosphoinositide
inositide-specific phospholipase Cbeta1. Adv Enzyme Regul.
2006;46:2-11. Epub 2006 Jul 18. Review. PubMed PMID:
16846636.
32
: Follo MY, Bosi C, Finelli C, Fiume R, Faenza I, Ramazzotti
G, Gaboardi GC, Manzoli L, Cocco L. Real-time PCR as a tool for
quantitative analysis of PI-PLCbeta1 gene expression in
myelodysplastic syndrome.
Int J Mol Med. 2006 Aug;18(2):267-71. PubMed PMID: 16820933. (IF:
1.957)
31
: Cocco L, Faenza I, Fiume R, Maria Billi A, Gilmour RS,
Manzoli FA.
Phosphoinositide-specific phospholipase C (PI-PLC) beta1 and
nuclear lipid-dependent signaling. Biochim Biophys Acta. 2006
May-Jun;1761(5-6):509-21.Epub 2006 Mar 29. Review. PubMed PMID:
16624616. (IF: 3,848)
30
: Martelli AM, Faenza I, Billi AM, Manzoli L, Evangelisti C,
Falà F, Cocco L. Intranuclear 3'-phosphoinositide metabolism and
Akt signaling: new mechanisms for tumorigenesis and protection
against apoptosis? Cell Signal. 2006 Aug;18(8):1101-7. Epub 2006
Mar 3. Review. PubMed PMID: 16516442. . (IF: 4,060)
29
: Faenza I, Billi AM, Follo MY, Fiume R, Martelli AM, Cocco
L, Manzoli L. Nuclear phospholipase C signaling through type 1 IGF
receptor and its involvement in cell growth and differentiation.
Anticancer Res. 2005 May-Jun;25(3B):2039-41. Review. PubMed PMID:
16158942.(IF: 1,725)
28
: Martelli AM, Fiume R, Faenza I, Tabellini G, Evangelista
C, Bortul R, Follo MY, Falà F, Cocco L. Nuclear phosphoinositide
specific phospholipase C(PI-PLC)-beta 1: a central intermediary in
nuclear lipid-dependent signal transduction. Histol Histopathol.
2005 Oct;20(4):1251-60. Review. PubMed PMID:16136505.(IF:
2,28)
27
: Manzoli L, Martelli AM, Billi AM, Faenza I, Fiume R, Cocco
L. Nuclear phospholipase C: involvement in signal transduction.
Prog Lipid Res. 2005 Jul;44(4):185-206. Epub 2005 Apr 26. Review.
PubMed PMID: 15896848. (IF: 11,237)
26
: Fiume R, Faenza I, Matteucci A, Astolfi A, Vitale M,
Martelli AM, Cocco L. Nuclear phospholipase C beta1 (PLCbeta1)
affects CD24 expression in murine erythroleukemia cells. J Biol
Chem. 2005 Jun24;280(25):24221-6. Epub 2005 Apr 22. PubMed PMID:
15849202.(IF: 4,651)
25
: Faenza I, Bavelloni A, Fiume R, Santi P, Martelli AM,
Maria Billi A, Lo Vasco VR, Manzoli L, Cocco L. Expression of
phospholipase C beta family isoenzymes in C2C12 myoblasts during
terminal differentiation. J Cell Physiol. 2004 Aug;200(2):291-6.
PubMed PMID: 15174099. (IF:4,218)
24
: Martelli AM, Falà F, Faenza I, Billi AM, Cappellini A,
Manzoli L, Cocco L. Metabolism and signaling activities of nuclear
lipids. Cell Mol Life Sci. 2004 May;61(10):1143-56. Review. PubMed
PMID: 15141300.(IF: 5.615)
23
: Merlo Pich M, Raule N, Catani L, Fagioli ME, Faenza I,
Cocco L, Lenaz G. Increased transcription of mitochondrial genes
for Complex I in human platelets during ageing. FEBS Lett. 2004 Jan
30;558(1-3):19-22. PubMed PMID: 14759509. (IF:4,25)
22
: Martelli AM, Faenza I, Billi AM, Falà F, Cocco L, Manzoli
L. Nuclear protein kinase C isoforms: key players in multiple cell
functions? Histol Histopathol.2003 Oct;18(4):1301-12. Review.
PubMed PMID: 12973696.(IF: 2.281)
21
: Faenza I, Bavelloni A, Fiume R, Lattanzi G, Maraldi NM,
Gilmour RS, Martelli AM, Suh PG, Billi AM, Cocco L.
Up-regulation of nuclear PLCbeta1 in myogenic differentiation. J
Cell Physiol. 2003 Jun;195(3):446-52. PubMed PMID: 12704654.
(IF:4,218)
20
: Martelli AM, Manzoli L, Faenza I, Bortul R, Billi A, Cocco
L. Nuclear inositol lipid signaling and its potential involvement
in malignant transformation. Biochim Biophys Acta. 2002 Oct
2;1603(1):11-7. Review. PubMed PMID: 12242107. (I.F.:
10,11)
19
: Martelli AM, Bortul R, Tabellini G, Faenza I, Cappellini
A, Bareggi R, Manzoli L, Cocco L. Molecular characterization of
protein kinase C-alpha binding to lamin A. J Cell Biochem.
2002;86(2):320-30. PubMed PMID: 12112001. (I.F.: 3,06)
18
: Faenza I, Matteucci A, Bavelloni A, Marmiroli S, Martelli
AM, Gilmour RS, Suh PG, Manzoli L, Cocco L. Nuclear PLCbeta(1) acts
as a negative regulator of p45/NF-E2 expression levels in Friend
erythroleukemia cells. Biochim Biophys Acta. 2002 May
8;1589(3):305-10. PubMed PMID: 12031797. (I.F.: 4,94)
17
: Ponti C, Falconi M, Billi AM, Faenza I, Castorina S, Caimi
L, Cacchioli A, Cocco L, Vitale M. IL-12 and IL-15 induce
activation of nuclear PLCbeta in human natural killer cells. Int J
Oncol. 2002 Jan;20(1):149-53. PubMed PMID: 11743656. (I.F.:
2,65)
16
: Martelli AM, Billi AM, Manzoli L, Faenza I, Aluigi M,
Falconi M, De Pol A, Gilmour RS, Cocco L. Insulin selectively
stimulates nuclear phosphoinositide-specific phospholipase C
(PI-PLC) beta1 activity through amitogen-activated protein (MAP)
kinase-dependent serine phosphorylation. FEBS Lett. 2000 Dec
15;486(3):230-6. PubMed PMID: 11119709. (IF:4,25)
15
: Faenza I, Matteucci A, Manzoli L, Billi AM, Aluigi M,
Peruzzi D, Vitale M,Castorina S, Suh PG, Cocco L. A role for
nuclear phospholipase Cbeta 1 in cell cycle control. J Biol Chem.
2000 Sep 29;275(39):30520-4. PubMed PMID: 10913438. (I.F.:
4,65)
14
: Peruzzi D, Calabrese G, Faenza I, Manzoli L, Matteucci A,
Gianfrancesco F,Billi AM, Stuppia L, Palka G, Cocco L.
Identification and chromosomal localisation by fluorescence in situ
hybridisation of human gene ofphosphoinositide-specific
phospholipase C beta(1). Biochim Biophys Acta. 2000 Apr
12;1484(2-3):175-82. PubMed PMID: 10760467. (I.F.: 4,94)
13
: Bavelloni A, Faenza I, Aluigi M, Ferri A, Toker A, Maraldi
NM, Marmiroli S. Inhibition of phosphoinositide 3-kinase impairs
pre-commitment cell cycle traverse and prevents differentiation in
erythroleukaemia cells. Cell Death Differ. 2000 Jan;7(1):112-7.
PubMed PMID: 10713726. (I.F.: 8,37)
12
: Manzoli L, Billi AM, Faenza I, Matteucci A, Martelli AM,
Peruzzi D, Falconi M, Rhee SG, Gilmour RS, Cocco L. Nuclear
phospholipase C: a novel aspect of phosphoinositide signalling.
Anticancer Res. 1999 Sep-Oct;19(5A):3753-6. Review. PubMed
PMID: 10625953. (I.F. : 1,7)
11
: Cocco L, Rubbini S, Manzoli L, Billi AM, Faenza I, Peruzzi
D, Matteucci A, Artico M, Gilmour RS, Rhee SG.
Inositides in the nucleus: presence and characterisation of the
isozymes of phospholipase beta family in NIH 3T3 cells. Biochim
Biophys Acta. 1999 May 18;1438(2):295-9. PubMed PMID: 10320812.
(I.F. 4,94)
10
: Bavelloni A, Santi S, Sirri A, Riccio M, Faenza I, Zini N,
Cecchi S, Ferri A, Auron P, Maraldi NM, Marmiroli S.
Phosphatidylinositol 3-kinase translocation to the nucleus is
induced by interleukin 1 and prevented by mutation of interleukin 1
receptor in human osteosarcoma Saos-2 cells. J Cell Sci. 1999
Mar;112 ( Pt5):631-40. PubMed PMID: 9973598. (IF: 5.877)
9
: Matteucci A, Faenza I, Gilmour RS, Manzoli L, Billi AM,
Peruzzi D, Bavelloni A, Rhee SG, Cocco L. Nuclear but not
cytoplasmic phospholipase C beta 1 inhibits differentiation of
erythroleukemia cells. Cancer Res. 1998 Nov
15;58(22):5057-60.PubMed PMID: 9823310. (IF: 8,650)
8
: Marmiroli S, Bavelloni A, Faenza I, Sirri A, Ognibene A,
Cenni V, Tsukada J, Koyama Y, Ruzzene M, Ferri A, Auron PE, Toker
A, Maraldi NM.
Phosphatidylinositol3-kinase is recruited to a specific site in the
activated IL-1 receptor I. FEBS Lett. 1998 Oct 30;438(1-2):49-54.
PubMed PMID: 9821957. (IF:4,25)
7
: Billi AM, Matteucci A, Faenza I, Manzoli L, Rubbini S,
Gilmour RS, Rhee SG, Cocco L. Control of expression of PLCbeta1 by
LAC repressor system: relationship between nuclear PLCbeta1
overexpression and growth factor stimulation. Biochem Biophys Res
Commun. 1997 Dec 8;241(1):122-6. PubMed PMID: 9405244. (IF:
2.406)
6
: Flamigni F, Faenza I, Marmiroli S, Stanic' I, Giaccari A,
Muscari C, Stefanelli C, Rossoni C. Inhibition of the expression of
ornithine decarboxylase and c-Myc by cell-permeant ceramide in
difluoromethylornithine-resistant leukaemia cells. Biochem J. 1997
Jun 15;324 ( Pt 3):783-9. PubMed PMID: 9210401; PubMed Central
PMCID: PMC1218493. (IF: 4.654)
5
: Manzoli L, Billi AM, Rubbini S, Bavelloni A, Faenza I,
Gilmour RS, Rhee SG, Cocco L. Essential role for nuclear
phospholipase C beta1 in insulin-like growth factor I-induced
mitogenesis.
Cancer Res. 1997 Jun 1;57(11):2137-9. PubMed PMID: 9187110. (IF:
8,650)
4
: Zini N, Sabatelli P, Faenza I, Ognibene A, Maraldi
NM.
Interleukin-1 alpha induces variations of the intranuclear amount
of phosphatidylinositol 4,5-bisphosphate and phospholipase C beta 1
in human osteosarcoma Saos-2 cells.
Histochem J. 1996 Jul;28(7):495-504. PubMed PMID: 8872139. (IF:
1,5)
3
: Marmiroli S, Zini N, Bavelloni A, Faenza I, Ognibene A,
Maraldi NM.
Transfected Saos-2 cells overexpressing phosphoinositidase C beta 1
isoformaccumulate it within the nucleus.
Biol Cell. 1996;86(2-3):121-6. PubMed PMID:8893501.(IF:
3.488)
2
: Zini N, Ognibene A, Marmiroli S, Bavelloni A, Maltarello MC,
Faenza I, Valmori A, Maraldi NM.
The intranuclear amount of phospholipase C beta 1 decreases
following cell differentiation in Friend cells, whereas gamma 1
isoformis not affected. Eur J Cell Biol. 1995 Sep;68(1):25-34.
PubMed PMID: 8549587.(IF: 3.213)
1
: Falcieri E, Gobbi P, Cataldi A, Zamai L, Faenza I, Vitale
M. Nuclear pores in the apoptotic cell. Histochem J. 1994
Sep;26(9):754-63. PubMed PMID: 7843986. (IF: 1,5)